These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32095934)

  • 1. Thermodynamic, Spatial and Methodological Considerations for the Manufacturing of Therapeutic Polymer Nanoparticles.
    Maslanka Figueroa S; Fleischmann D; Beck S; Goepferich A
    Pharm Res; 2020 Feb; 37(3):59. PubMed ID: 32095934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spermidine-mediated poly(lactic-
    Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J
    Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy.
    Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z
    Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ligand lipophilicity on the nanoparticle encapsulation of Pt(IV) prodrugs.
    Johnstone TC; Lippard SJ
    Inorg Chem; 2013 Sep; 52(17):9915-20. PubMed ID: 23859129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
    Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
    Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
    Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT
    Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure.
    Haggag YA; Faheem AM; Tambuwala MM; Osman MA; El-Gizawy SA; O'Hagan B; Irwin N; McCarron PA
    Pharm Dev Technol; 2018 Apr; 23(4):370-381. PubMed ID: 28285551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidic Manufacturing of Multitargeted PLGA/PEG Nanoparticles for Delivery of Taxane Chemotherapeutics.
    Martins C; Sarmento B
    Methods Mol Biol; 2020; 2059():213-224. PubMed ID: 31435924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The remarkable role of emulsifier and chitosan, dextran and PEG as capping agents in the enhanced delivery of curcumin by nanoparticles in breast cancer cells.
    Sampath M; Pichaimani A; Kumpati P; Sengottuvelan B
    Int J Biol Macromol; 2020 Nov; 162():748-761. PubMed ID: 32585267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of size-tunable sub-200 nm PLGA-based nanoparticles with a wide size range using a microfluidic platform.
    Bao Y; Maeki M; Ishida A; Tani H; Tokeshi M
    PLoS One; 2022; 17(8):e0271050. PubMed ID: 35925917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.
    Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT
    Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
    Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R
    Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of parameters for preparation of docetaxel-loaded PLGA nanoparticles by nanoprecipitation method.
    Shi W; Zhang ZJ; Yuan Y; Xing EM; Qin Y; Peng ZJ; Zhang ZP; Yang KY
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):754-758. PubMed ID: 24142732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable Poly (Lactic-co-Glycolic Acid)-Polyethylene Glycol Nanocapsules: An Efficient Carrier for Improved Solubility, Bioavailability, and Anticancer Property of Lutein.
    Arunkumar R; Prashanth KVH; Manabe Y; Hirata T; Sugawara T; Dharmesh SM; Baskaran V
    J Pharm Sci; 2015 Jun; 104(6):2085-2093. PubMed ID: 25824524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations.
    Bonelli P; Tuccillo FM; Federico A; Napolitano M; Borrelli A; Melisi D; Rimoli MG; Palaia R; Arra C; Carinci F
    Int J Nanomedicine; 2012; 7():5683-91. PubMed ID: 23180963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.